- Home
- ARVN vs USA Comparison
ARVN vs USA Comparison
Compare ARVN & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- USA
- Stock Information
- Founded
- ARVN 2015
- USA 1986
- Country
- ARVN United States
- USA United States
- Employees
- ARVN N/A
- USA N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- USA Finance Companies
- Sector
- ARVN Health Care
- USA Finance
- Exchange
- ARVN Nasdaq
- USA Nasdaq
- Market Cap
- ARVN 1.7B
- USA 2.0B
- IPO Year
- ARVN 2018
- USA N/A
- Fundamental
- Price
- ARVN $25.11
- USA $7.20
- Analyst Decision
- ARVN Strong Buy
- USA
- Analyst Count
- ARVN 13
- USA 0
- Target Price
- ARVN $61.08
- USA N/A
- AVG Volume (30 Days)
- ARVN 718.1K
- USA 880.5K
- Earning Date
- ARVN 10-30-2024
- USA 01-01-0001
- Dividend Yield
- ARVN N/A
- USA 9.66%
- EPS Growth
- ARVN N/A
- USA N/A
- EPS
- ARVN N/A
- USA N/A
- Revenue
- ARVN $161,100,000.00
- USA N/A
- Revenue This Year
- ARVN $237.44
- USA N/A
- Revenue Next Year
- ARVN N/A
- USA N/A
- P/E Ratio
- ARVN N/A
- USA N/A
- Revenue Growth
- ARVN 1.07
- USA N/A
- 52 Week Low
- ARVN $21.17
- USA $5.62
- 52 Week High
- ARVN $53.08
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- ARVN 48.81
- USA 48.75
- Support Level
- ARVN $21.17
- USA $7.03
- Resistance Level
- ARVN $28.70
- USA $7.49
- Average True Range (ATR)
- ARVN 1.72
- USA 0.09
- MACD
- ARVN -0.41
- USA -0.02
- Stochastic Oscillator
- ARVN 51.44
- USA 39.80
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.